An open label study to investigate the safety and tolerability of GK Activator (2) in patients with type 2 diabetes mellitus not adequately controlled with glimepiride as a standard prescribed therapy.
Phase of Trial: Phase I
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Glimepiride; Piragliatin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Roche
- 23 Feb 2010 Actual initiation date (Aug 2006) added as reported by Roche.
- 08 Jan 2008 New trial record.